Viewing Study NCT00317434


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-26 @ 4:44 PM
Study NCT ID: NCT00317434
Status: TERMINATED
Last Update Posted: 2009-12-15
First Post: 2006-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Sponsor: University of Alabama at Birmingham
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module